Invivyd (IVVD) Net Equity Issued and Repurchased (2021 - 2025)

Invivyd (IVVD) posted Net Equity Issued and Repurchased of $10.9 million for Q4 2025, up 13874.36% on a QoQ basis from $78000.0 in Q2 2025, and up 33962.5% year-over-year from N/an in Q4 2024.

Invivyd (IVVD) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends

Invivyd's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $10.9 million for Q4 2025.

  • Quarterly Net Equity Issued and Repurchased rose 33962.5% year-over-year to $10.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (up 4856.95% YoY) and the FY2025 annual result came in at $254000.0, up 13.9% from the prior year.
  • Net Equity Issued and Repurchased was $10.9 million for Q4 2025 at Invivyd, up from $78000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $335.2 million in Q4 2021 and bottomed at -$335.3 million in Q3 2021.
  • A 5-year average of $776866.7 and a median of $75000.0 in 2024 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased sank 99.96% — and 2025, when it jumped 33962.5%.
  • Invivyd's Net Equity Issued and Repurchased stood at $335.2 million in 2021, then sank by 99.96% to $120000.0 in 2022, then slumped by 63.33% to $44000.0 in 2023, then dropped by 27.27% to $32000.0 in 2024, then soared by 33962.5% to $10.9 million in 2025.
  • Business Quant data shows IVVD's Net Equity Issued and Repurchased at $10.9 million in Q4 2025, $78000.0 in Q2 2025, and $44000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 141.90 Mn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn 10.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.90 Mn
Dec 31, 2025 10.90 Mn
Jun 30, 2025 78,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 44,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 32,000.00
Dec 31, 2024 32,000.00
Sep 30, 2024 27,000.00
Sep 30, 2024 27,000.00
Jun 30, 2024 75,000.00
Jun 30, 2024 75,000.00
Mar 31, 2024 89,000.00
Mar 31, 2024 89,000.00
Dec 31, 2023 44,000.00
Dec 31, 2023 44,000.00
Sep 30, 2023 57,000.00
Sep 30, 2023 57,000.00
Jun 30, 2023 56,000.00
Jun 30, 2023 56,000.00